Is AstraZeneca a Buy as It Eyes the Weight Loss Market?
While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...
Truth about weight-loss jabs: Doctors reveal everyday habits which raise your risk of deadly side effects, why Mounjaro is riskier than Ozempic and the little-known sign …
After a nurse died after just two weight-loss injections of Mounjaro - which is approved for use on the NHS - here's ...
Comedian Jim Gaffigan admits using weight loss drug Mounjaro to shed 50lbs
Jim Gaffigan has a sleek new look to match his recent Hollywood renaissance, which includes his hilarious turn on SNL as vice ...
Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?
Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...
Al Jazeera on MSN1h
Could weight loss drugs fix UK’s unemployment problem?
The United Kingdom will study whether the use of weight loss drugs could get people back to work. UK Health Minister Wes ...
Comedian Jim Gaffigan Says He Lost 50 Lbs. with the Help of Mounjaro: ‘It's Such a Better Life’ (Exclusive)
Gaffigan slimmed down using Mounjaro, which is a brand name for tirzepatide, a prescription drug used to treat type 2 ...
Cover Media US on MSN6h
Weight-loss drug gave Jim Gaffigan a 'better life'
Jim Gaffigan has revealed using a weight-loss drug gave him a "better life". The comedian wants to challenge the stigma ...
New weight loss drug better than Ozempic, without causing nausea?
Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...
99% Of Mounjaro/Zepbound Patients Remained Diabetes-Free Even At 3 Years, Eli Lilly's Detailed Phase 3 Data Shows
Eli Lilly's Phase 3 study shows tirzepatide significantly cuts type 2 diabetes risk and supports 22.9% average weight loss in adults over three years.
Monthly Prescribing Reference13h
Long-Term Tirzepatide Treatment Reduces Weight and Diabetes Progression Risk
The detailed results were published in The New England Journal of Medicine and were presented at ObesityWeek 2024.
Insight News9h
Weight loss plans are less effective for many Black women − because existing ones often don’t meet their unique needs
The popularity of weight loss drugs such as Ozempic and Mounjaro continue to reflect Americans’ desire to slim down. While ...
2 Top Growth Stocks to Buy on the Dip
Has something changed regarding Eli Lilly or Regeneron's thesis, or is the recent dip an excellent opportunity to invest in ...